POOLED FREQUENCY OF STROKE WITHIN 30-DAYS FOLLOWING MECHANICAL CIRCULATORY SUPPORT WITH IMPELLA 5.0®/LD® DEVICE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF STUDIES PUBLISHED IN THE LAST DECADE (2009-2019)

Outcomes of mechanical circulatory support (MCS) with the Impella 5.0/LD (Abiomed Inc, Danvers, MA) device have been increasingly studied in the last few years. However, pooled prevalence of stroke following Impella 5.0/LD support remains unclear. We analyzed pooled rates of stroke (in-hospital or